muraloncology.com - Bathi operasional EBITDA MURA
Mural Oncology plc (MURA) maintains an impeccable reputation for developing cutting-edge immunotherapeutic agents against tumors. Stable demand for treatment renders the business independent of GDP, and cash operating profit before deductions confirms this resilience. The 0.00 level captures the latest values of this metric. The company's environmental footprint is minimal due to digital documentation and strict control over the disposal of chemical reagents.
Mural Oncology - rincian analitis lan metrik utama (MURA)
- kuotasi saiki lan rata-rata prakiraan nilai:
- rincian nilai pasar emiten:
- indikator nilai buku ekuitas:
- data tingkat utang lan likuiditas finansial:
Rasio Total Utang marang Ekuitas Mural Oncology plc|MURA - Rasio utang jangka dawa marang ekuitas|Utang jangka cendhak marang modal Mural Oncology PLC|MURA - Utang perusahaan|Rasio utang marang aset resik Mural Oncology|MURA - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Mural Oncology|Likuiditas cepet muraloncology.com
- statistik bathi lan rasio pasar:
MURA - Penghasilan resik|Penghasilan resik sing dikarepake Mural Oncology plc|MURA - Rasio rega marang bathi|Rasio prakiraan rega marang bathi Mural Oncology PLC|MURA - Rasio rega marang bathi tumrap wutah|Nilai perusahaan marang bathi operasional sadurunge panyusutan Mural Oncology|MURA - Bathi operasional EBITDA|Bathi resik saben saham sajrone 12 wulan pungkasan Mural Oncology|MURA - Bathi saben saham sajrone rolas wulan pungkasan|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan muraloncology.com|MURA - Wutah bathi saben saham ing taun lumaku|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Mural Oncology plc
Analisis kabeh metrik perusahaan:Mural Oncology plc
This metric reflects the aggregate cash flow from core operations before deducting tax and interest obligations, serving as a fundamental indicator of the issuer's operational efficiency and financial autonomy. For Mural Oncology plc (MURA), the absolute EBITDA level demonstrates the company's ability to monetize developments in cytokine therapy, allowing investors to assess the resilience of the business model against the costs of creating low-toxicity interleukins.
Karo sapa Mural Oncology plc saingan
ONC - Bathi operasional sadurunge ngurangi amortisasi|HALO: Bathi operasional sadurunge ngurangi amortisasi|RVMD - Bathi operasional EBITDA|Ascentage Pharma (AAPG) - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|CG Oncology Inc - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|URGN (UroGen) - Bathi operasional EBITDA|Bathi sadurunge bunga, pajak, lan amortisasi Bicara Corp BCAX|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Personalis, Inc. (PSNL)|Bathi operasional sadurunge ngurangi amortisasi erasca.com ERAS|Delcath Systems - Bathi operasional sadurunge ngurangi amortisasi|Bathi operasional EBITDA Y-mAbs Therapeutics Inc YMAB|AURA - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi CADL (Candel Therapeutics)|ARAY: Bathi operasional EBITDA|SELLAS Life Sciences Group (SLS) - Bathi operasional EBITDA|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Actuate Therapeutics|Bathi sadurunge mbayar bunga, pajak, lan amortisasi CTOR|Bathi operasional sadurunge ngurangi amortisasi HURA (TuHURA Biosciences, Inc.)|TARA (Protara Tx) - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Fate Therapeutics, Inc. FATE|Aadi Bioscience, Inc. (WHWK) - Bathi sadurunge bunga, pajak, lan amortisasi|TCRX - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|CSBR (Champions Oncology) - Bathi operasional sadurunge amortisasi|XBIT: Bathi operasional EBITDA|Bathi operasional sadurunge ngurangi amortisasi CEL-SCI|Bathi sadurunge mbayar bunga, pajak, lan amortisasi OS Therapies Incorporated|Bathi sadurunge bunga, pajak, lan amortisasi radiopharmtheranostics.com RADX|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Artiva Biotherapeutics, Inc. (ARTV)|Bathi sadurunge mbayar bunga, pajak, lan amortisasi ANL (adlainortye.com)|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Veru Pharma VERU|Tempest Therapeutics Corp (TPST) - Bathi sadurunge bunga, pajak, lan amortisasi|Xilio - Bathi operasional EBITDA|Bathi operasional sadurunge potongan amortisasi Renovaro Inc. (RENB)|KAPA (kairospharma.com) - Bathi operasional sadurunge ngurangi amortisasi|Bathi sadurunge bunga, pajak, lan amortisasi OnKure Therapeutics (OKUR)|Bathi operasional sadurunge ngurangi amortisasi GDTC|CRIS: Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Apollomics, Inc. (APLM)|THAR: Bathi sadurunge ngurangi bunga, pajak, penyusutan, lan amortisasi|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Advanced Biomed ADVB|Genprex Inc. - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Calidi Bio - Bathi operasional EBITDA|sunshinebiopharma.com (SBFM) - Bathi operasional sadurunge ngurangi amortisasi|xeneticbio.com (XBIO) - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi operasional sadurunge ngurangi amortisasi salariuspharma.com|Bathi operasional sadurunge ngurangi amortisasi PPBT|Bathi operasional EBITDA AON|Bathi sadurunge mbayar bunga, pajak, lan amortisasi BeOne Medicines (BGNE)|CKPT (Checkpoint Therapeutics Inc) - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi operasional EBITDA ELEV (Elevation Oncology)|Bathi operasional EBITDA iCAD Inc. ICAD|Ikena - Bathi operasional EBITDA|Notable Labs Ltd (NTBL) - Bathi operasional sadurunge ngurangi amortisasi|VIRX: Bathi operasional EBITDA|MorphoSys Corporation (MOR) - Bathi operasional EBITDA|Bathi sadurunge mbayar bunga, pajak, lan amortisasi NAYA Biosciences|Bathi operasional sadurunge amortisasi AAPGV (ascentage.com)
